ING4-expressing Oncolytic Herpes Simplex Virus 2 (ΔRL), CMV-ING4(Cat#: CyOV-0300XY)

This product is a ING4 expressing oncolytic herpes simplex virus, which is based on HSV-2 with RL deleted. The deletion lies entirely within the sequences deleted in JH2604 in which only 850 bp are removed from the RL. This product can be used in oncolytic virotherapy research and further recombinant HSV construction.

Specifications

Family Herpesviridae
Species Herpes simplex virus
Serotype Herpes simplex virus 2
Backbone HSV-2 (ΔRL)
Backbone Background Herpes simplex virus 1 and 2 (HSV-1 and HSV-2), also known as human herpesvirus 1 and 2 (HHV-1 and HHV-2), are two members of the human Herpesviridae family, a set of viruses that produce viral infections in the majority of humans. Modified Herpes simplex virus is considered as a potential therapy for cancer and has been extensively clinically tested to assess its oncolytic ability.
Gene Modification ΔRL
Promoter CMV
Transgene ING4
Type of Transgene Cytokine
Related Target/Protein Inhibitor of growth family member 4
Capsid Modification None
Titer >1*10^8 PFU
Related Diseases Tumor

Transgene

Alternative Names ING4, my036, p29ING4, inhibitor of growth family member 4
Gene ID 51147

Information

Introduction Inhibitor of growth protein 4 is a protein that in humans is encoded by the ING4 gene.

Customer Reviews and Q&As

There are currently no customer reviews or questions for ING4-expressing Oncolytic Herpes Simplex Virus 2 (ΔRL), CMV-ING4 (CyOV-0300XY). Click the button below to contact us or submit your feedback about this product.

All products and services are for Research Use Only. Not For Clinical Use.

Other products

PRODUCTS

Online Inquiry